The studies below compared protection seen in surgically treated/immunized EMT6 or 4THM tumor injected WT mice with/without manipulation of CD200:CD200R interactions using Fab anti-CD200R, with attenuation of disease after surgical resection followed by chemotherapy. Here, CD200R1 is linked to neoplasm.